Loading organizations...
§ Private Profile · Miami, FL, USA
Nutraceuticals company offering science-backed functional wellness shots for health-conscious consumers, focused on immunity, recovery, and organ health.
Dose has raised $10.7M across 3 funding rounds.
Dose has raised $10.7M in total across 3 funding rounds.
Dose is a direct-to-consumer wellness company operating from an undisclosed location that develops and sells science-backed functional health shots combining traditional herbal ingredients like turmeric with modern clinical formulations. The organization targets the broader nutraceutical market by offering specialized liquid supplements designed to address specific consumer health needs, including liver function, skin health, muscle recovery, and overall immunity. Amid rising consumer demand for preventative health products during the COVID-19 pandemic, the enterprise officially launched its initial product line consisting of four distinct functional wellness shots in August 2020. To formulate and manufacture these targeted health solutions, the company established a strategic research and development partnership with Tirupati Research, a specialized manufacturing and formulation firm originally established in 2005. Operating primarily through a digital e-commerce business model, Dose was founded in 2020 by Vasu Goyal.
Dose has raised $10.7M across 3 funding rounds. Most recently, it raised $670K Seed in January 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 1, 2022 | $670K Seed | — | Haatch, Hoxton Ventures, Outrun Ventures, Stride VC, Evelyn Bourke | Announced |
| Oct 31, 2013 | $8M Series A | — | Charlie Anderson, John Compton, Gary Holdren | Announced |
| Dec 1, 2011 | $2M Series U | — | Listen | Announced |
Dose has raised $10.7M in total across 3 funding rounds.
Dose's investors include Haatch, Hoxton Ventures, Outrun Ventures, Stride VC, Evelyn Bourke, Charlie Anderson, John Compton, Gary Holdren, Listen.
Dose is a Chicago-based digital media company (with HQ listed in Los Angeles) operating Dose.com and OMGFacts.com, recognized as one of the world's fastest-growing digital media firms.[1] It builds a predictive technology platform that detects "stories worth sharing," enabling editors to curate and publish content to targeted audiences, educating, entertaining, and inspiring over 30 million monthly visitors.[1] Dose serves a global online audience seeking engaging digital content and solves the problem of content discovery and distribution in a crowded media landscape by leveraging advanced technology for personalized sharing.[1]
The company demonstrates strong growth momentum, scaling to 50 total employees since its founding in 2009, and positions itself as the world's most technologically advanced digital media company.[1]
Founded in 2009, Dose emerged as a digital media innovator behind sites like Dose.com and OMGFacts.com, initially based in Chicago before listing Los Angeles as its HQ.[1] While specific founders are not detailed in available sources, the company quickly gained traction by focusing on high-engagement storytelling, evolving into a tech-driven publisher that combines editorial expertise with predictive algorithms to identify viral-worthy content.[1] Early pivotal moments include building a platform that now reaches over 30 million monthly visitors, marking its shift from traditional media to a data-powered model.[1]
(Note: Other "Dose" entities exist, such as a wellness shots company in food/beverage[2][3] or a UK tech firm,[4] but the query's "technology company" aligns with the digital media profile.[1])
Dose rides the wave of AI-driven content personalization and predictive analytics in digital media, where algorithms prioritize user engagement amid declining traditional ad models.[1] Timing is ideal in a post-pandemic era of explosive social media consumption, with market forces like short-form video and viral storytelling favoring tech-savvy publishers over legacy outlets.[1] It influences the ecosystem by pioneering scalable, editor-tech hybrids, potentially shaping how media firms integrate AI for audience targeting and content virality.
Dose is poised to expand its predictive platform amid rising demand for hyper-personalized media, potentially integrating generative AI for content creation or deeper e-commerce ties.[1] Trends like multimodal AI and privacy-focused personalization will shape its path, amplifying reach beyond 30 million users. Its influence may evolve from pure publisher to full-stack media tech provider, solidifying its edge in a fragmented digital landscape—echoing its founding promise as a technologically advanced disruptor.[1]